How do you manage a patient with widely metastatic serous endometrial cancer whose disease is stable after completion of 6 cycles of chemotherapy + immunotherapy?

Community
Company
News
Contact Us
Sign in

Topics: Gynecologic Cancers • Endometrial Cancer

She continues to have hypermetabolic nodes in bilateral external iliac and axillary nodes, as well as a hypermetabolic 16cm uterus.

Related Questions

How long would you wait to start next-line chemotherapy in a patient recovering from grade 3 immune-mediated hepatitis secondary to lenvatinib/pembrolizumab for endometrial cancer?

In light of new NCCN guidelines that state combination chemotherapy + pelvic RT should be reserved for endometrial cancer of at least stage IIIB, will you recommend EBRT in addition to chemotherapy for stage IIIA endometrial cancers?

Do you recommend a completion hysterectomy to patients who undergo primary radiation for endometrial cancer (presuming they are now a surgical candidate)?

For a diabetic patient with presumed stage I Grade 1 endometrial cancer, what Hemoglobin A1C level would prompt you to recommend medical management instead of surgery?

When do you expect the 2023 FIGO staging for endometrial cancer to become adopted clinically in the US?

Would you consider offering immunotherapy +/- olaparib to a patient with early-stage endometrial carcinoma for whom you are recommending adjuvant chemotherapy based on improved outcomes seen in RUBY/DUO-E/NRG-GY018?

How would you manage a POLE mutated, p53 abnormal IA myoinvasive carcinosarcoma of the endometrium with no LVSI?

What do you view as the future role for the combination of durvalumab + olaparib + chemotherapy in the management of patients with advanced/recurrent endometrial cancer following the DUO-E trial results?

Is it ever acceptable to treat low pelvis (vs. whole pelvis) for an early vaginal recurrence of endometrial cancer?

Would you offer pelvic radiation in a patient with Stage IIIC endometrial cancer who has Crohn's disease and a permanent ileostomy?